ZNA Cadix

Antwerp 2030

3 studies enrolling now · 6 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma — Stopped early